In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. These tests can be performed in stand-alone laboratories, and hospitals- Some of the significant technologies incorporated in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. Research Beam Model: Research Beam Product ID: 2030292 5370 USD New
IVD Market by Product Type (Reagents, Instruments and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
 

IVD Market by Product Type (Reagents, Instruments and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

IVD Market by Product Type (Reagents, Instruments and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tis

Category : Healthcare
Published On : September  2017
Pages : 240

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. These tests can be performed in stand-alone laboratories, and hospitals- Some of the significant technologies incorporated in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.

There is a growth in need of IVD testing due to increase in incidences of chronic and infectious diseases and rise in geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases boost the growth of the IVD market. In addition, increase in incidences of colorectal cancer, neurological disorders, and gynecological diseases boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavorable reimbursement policies limit the growth of the market. The global IVD market is accounted for $61,103 million in 2016, and is estimated to reach at $84,647 million by 2023, growing at a CAGR of 4.6% from 2017-2023.

The market is segmented on the basis of product type, techniques, application, end-user, and geography. By product type, the market is categorized into reagents, instruments, and software & services. On the basis of techniques, it is categorized into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end-user, it is divided into hospitals, academic and medical schools, point of care testing, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global IVD market, with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments facilitates to understand various products of the market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Techniques

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassays (CLIAS)
      • Fluorescence Immunoassays (FIAS)
      • Colorimetric Immunoassays (CIS)
    • Rapid Tests
    • Enzyme-Linked Immunospot Assays (ELISPOT)
    • Radioimmunoassay
    • Western Blot
  • Blood Testing
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA Diagnostics
    • Microarrays
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Renal Profile
    • Electrolyte Panel
    • Specialty Chemicals
  • Other IVD Techniques

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Other Indications

By End Users

  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Point of Care Testing
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

List of players profiled in the report

  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Biomerieux
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Becton Dickinson and Company
  • Bio-Rad Laboratories
  • Bayer AG
  • Sysmex Corporation
  • Johnson & Johnson

CHAPTER 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTERS FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

CHAPTER 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

CHAPTER 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

CHAPTER 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

CHAPTER 8 IVD MARKET BY GEOGRAPHY

8.1 OVERVIEW

8.1.1 Market size and forecast

8.2 NORTH AMERICA

8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 U.S.

8.2.4.1 Market size and forecast

8.2.5 Canada

8.2.5.1 Market size and forecast

8.2.6 Mexico

8.2.6.1 Market size and forecast

8.3 EUROPE

8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany

8.3.4.1 Market size and forecast

8.3.5 France

8.3.5.1 Market size and forecast

8.3.6 UK

8.3.6.1 Market size and forecast

8.3.7 SPAIN

8.3.7.1 Market size and forecast

8.3.8 ITALY

8.3.8.1 Market size and forecast

8.3.9 Rest of Europe

8.3.9.1 Market size and forecast

8.4 ASIA-PACIFIC

8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 India

8.4.4.1 Market size and forecast

8.4.5 China

8.4.5.1 Market size and forecast

8.4.6 Japan

8.4.6.1 Market size and forecast

8.4.7 Australia

8.4.7.1 Market size and forecast

8.4.8 South Korea

8.4.8.1 Market size and forecast

8.4.9 Rest of Asia-Pacific

8.4.9.1 Market size and forecast

8.5 LAMEA

8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Latin America

8.5.4.1 Market size and forecast

8.5.5 Middle East

8.5.5.1 Market size and forecast

8.5.6 Africa

8.5.6.1 Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 THERMO FISHER SCIENTIFIC INC.

9.1.1 Company overview
9.1.2 Business performance
9.1.3 Key strategies and development

9.2 ALERE INC.

9.2.1 Company overview
9.2.2 Business performance
9.2.3 Key strategies and developments

9.3 BIOMERIEUX

9.3.1 Company overview
9.3.2 Business performance
9.3.3 Key strategies and developments

9.4 DANAHER CORPORATION

9.4.1 Company overview
9.4.2 Business performance
9.4.3 Key strategies and development

9.5 F. HOFFMANN-LA ROCHE AG

9.5.1 Company overview
9.5.2 Business performance
9.5.3 Key strategies and developments

9.6 BECTON DICKINSON AND COMPANY

9.6.1 Company overview
9.6.2 Business performance
9.6.3 Key strategies and development

9.7 BIO-RAD LABORATORIES

9.7.1 Company overview
9.7.2 Business performance
9.7.3 Key strategies and developments

9.8 BAYER AG

9.8.1 Company overview
9.8.2 Business performance
9.8.3 Key strategies and development

9.9 SYSMEX CORPORATION

9.9.1 Company overview
9.9.2 Business performance
9.9.3 Key strategies and developments

9.10 JOHNSON & JOHNSON

9.10.1 Company overview
9.10.2 Business performance
9.10.3 Key strategies and development

List of Tables

TABLE 1 GLOBAL INCIDENCE OF DISEASES
TABLE 2 GLOBAL IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 GLOBAL IVD REAGENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4 GLOBAL IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5 GLOBAL IVD SOFTWARE & SERVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6 GLOBAL IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 GLOBAL IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 GLOBAL IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9 GLOBAL IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 GLOBAL IVD BLOOD TESTING TECHNIQUE MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11 GLOBAL IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 GLOBAL IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13 GLOBAL IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, BY GEOGRAPHY, 2016-2023, ($MILLION)
TABLE 14 GLOBAL IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15 GLOBAL OTHER IVD TECHNIQUES MARKET, BY GEOGRAPHY, 2016-2023, ($MILLION)
TABLE 16 GLOBAL IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 GLOBAL IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18 GLOBAL IVD CANCER MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19 GLOBAL IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20 GLOBAL IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21 GLOBAL IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2016-2023, ($MILLION)
TABLE 22 GLOBAL IVD GASTROINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23 GLOBAL IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24 GLOBAL IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 GLOBAL IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26 GLOBAL IVD HOSPITALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27 GLOBAL IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28 GLOBAL IVD POINT OF CARE MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29 GLOBAL IVD OTHER END-USER MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30 GLOBAL IVD MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31 NORTH AMERICA IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 32 NORTH AMERICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 33 NORTH AMERICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 34 NORTH AMERICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35 NORTH AMERICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 36 U.S. IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 37 U.S. IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 38 U.S. IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39 U.S. IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 40 CANADA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 41 CANADA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 42 CANADA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 43 CANADA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 44 MEXICO IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 45 MEXICO IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 46 MEXICO IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 47 MEXICO IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 48 EUROPE IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 49 EUROPE IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 50 EUROPE IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 51 EUROPE IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52 EUROPE IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 53 GERMANY IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 54 GERMANY IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 55 GERMANY IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 56 GERMANY IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 57 FRANCE IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 58 FRANCE IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 59 FRANCE IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60 FRANCE IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 61 UK IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 62 UK IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 63 UK IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64 UK IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 65 SPAIN IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 66 SPAIN IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 67 SPAIN IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 68 SPAIN IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 69 ITALY IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 70 ITALY IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 71 ITALY IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 72 ITALY IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 73 REST OF EUROPE IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 74 REST OF EUROPE IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 75 REST OF EUROPE IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 76 REST OF EUROPE IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 77 ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 78 ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 79 ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 80 ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 81 ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 82 INDIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 83 INDIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 84 INDIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85 INDIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 86 CHINA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 87 CHINA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 88 CHINA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 89 CHINA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 90 JAPAN IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 91 JAPAN IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 92 JAPAN IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 93 JAPAN IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 94 CATEGORIZATION OF IVD DEVICES
TABLE 95 AUSTRALIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 96 AUSTRALIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 97 AUSTRALIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 98 AUSTRALIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 99 SOUTH KOREA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 100 SOUTH KOREA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 101 SOUTH KOREA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 102 SOUTH KOREA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 103 REST OF ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 104 REST OF ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 105 REST OF ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 106 REST OF ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 107 LAMEA IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 108 LAMEA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 109 LAMEA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 110 LAMEA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 111 LAMEA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 112 LATIN AMERICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 113 LATIN AMERICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 114 LATIN AMERICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 115 LATIN AMERICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 116 MIDDLE EAST IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 117 MIDDLE EAST IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 118 MIDDLE EAST IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 119 MIDDLE EAST IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 120 AFRICA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 121 AFRICA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 122 AFRICA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 123 AFRICA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 124 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 125 ALERE INC. COMPANY SNAPSHOT
TABLE 126 BIOMERIEUX COMPANY SNAPSHOT
TABLE 127 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 128 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 129 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 130 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 131 BAYER AG COMPANY SNAPSHOT
TABLE 132 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 133 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTERS FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 GLOBAL CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 GLOBAL FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 GLOBAL COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 GLOBAL RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 GLOBAL ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 GLOBAL RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 GLOBAL WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 GLOBAL POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 GLOBAL ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 GLOBAL HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 GLOBAL DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 GLOBAL MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 GLOBAL OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 GLOBAL BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 GLOBAL LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 GLOBAL RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 GLOBAL LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 GLOBAL THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 GLOBAL ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 GLOBAL SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)

Enquiry Before Buy